ALFUWIN® XL


Prolonged-release tablets
scheduling status
S4
registration number
41/5.2/0740
What ALFUWIN® XL contains
Each prolonged-release tablet contains 10 mg alfuzosin hydrochloride.
other ingredients
Ethylcellulose Hydrogenated castor oil Hypromellose Magnesium stearate Mannitol Microcrystalline cellulose Povidone Hydrated colloidal silica Yellow ferric oxide (E172).
Therapeutic classification
G04C A01.
© 2026 SAHPRA. ALL RIGHTS RESERVED